Helius Medical Technologies Inc (HSDT)
1.85
-0.57
(-23.55%)
USD |
NASDAQ |
May 07, 16:00
1.85
0.00 (0.00%)
After-Hours: 19:46
Helius Medical Technologies Research and Development Expense (Quarterly): 0.65M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.65M |
September 30, 2023 | 0.722M |
June 30, 2023 | 0.684M |
March 31, 2023 | 0.886M |
December 31, 2022 | 0.794M |
September 30, 2022 | 0.751M |
June 30, 2022 | 0.953M |
March 31, 2022 | 1.764M |
December 31, 2021 | 1.808M |
September 30, 2021 | 1.489M |
June 30, 2021 | 1.377M |
March 31, 2021 | 1.316M |
December 31, 2020 | 0.827M |
September 30, 2020 | 1.327M |
June 30, 2020 | 1.308M |
March 31, 2020 | 1.12M |
December 31, 2019 | 1.599M |
September 30, 2019 | 1.506M |
June 30, 2019 | 2.275M |
March 31, 2019 | 2.681M |
December 31, 2018 | 2.158M |
Date | Value |
---|---|
September 30, 2018 | 2.309M |
June 30, 2018 | 2.921M |
March 31, 2018 | 2.552M |
December 31, 2017 | 3.266M |
September 30, 2017 | 3.798M |
June 30, 2017 | 4.295M |
March 31, 2017 | 3.028M |
September 30, 2016 | 1.348M |
June 30, 2016 | 0.6539M |
March 31, 2016 | 0.9817M |
December 31, 2015 | 1.292M |
September 30, 2015 | 0.0015M |
June 30, 2015 | 1.521M |
March 31, 2015 | 1.304M |
December 31, 2014 | 1.192M |
September 30, 2014 | 1.063M |
June 30, 2014 | 0.6533M |
March 31, 2014 | 0.1718M |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.65M
Minimum
Dec 2023
2.275M
Maximum
Jun 2019
1.219M
Average
1.308M
Median
Jun 2020
Research and Development Expense (Quarterly) Benchmarks
ARCA biopharma Inc | 0.165M |
Cerus Corp | 14.48M |
NeuroOne Medical Technologies Corp | 1.483M |
Perspective Therapeutics Inc | 6.08M |
Electromed Inc | 0.107M |